Adoptive Immunotherapy and High-Risk Myeloma

SIMPLE SUMMARY: Multiple myeloma is a cancer of the bone marrow which accounts for approximately 1.8% of all cancer diagnoses worldwide. The clinical outcomes for patients with multiple myeloma have significantly improved in the most recent decade, resulting in better quality of life and prolonged s...

Descripción completa

Detalles Bibliográficos
Autores principales: Duane, Catherine, O’Dwyer, Michael, Glavey, Siobhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177276/
https://www.ncbi.nlm.nih.gov/pubmed/37174099
http://dx.doi.org/10.3390/cancers15092633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177276/
https://www.ncbi.nlm.nih.gov/pubmed/37174099
http://dx.doi.org/10.3390/cancers15092633

Ejemplares similares